Home>
Stocks>
Pharma Stocks

Pharma Stocks

Name: Best Pharma Stocks - Pharma Sector Stocks to Buy
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.

Live Share Market

List of Pharma Stocks

Stocks categories

Pharma Stocks

The Pharma Stocks collection features companies involved in the research, development, manufacturing, and distribution of pharmaceuticals. This sector is characterized by high R&D expenditures, a focus on innovation, and the potential for substantial profit margins.

Filter

Sort by

Name	Price	M Cap	Analyst Rating	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Div Yld	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Sun Pharmaceutical Industries Ltd	₹1,685.40	Large Cap	BUY	1981.44	4.56%	9.36%	102.25%	251.79%	36.79	55.73	16.41	0.59	0.83%	2160.64 Cr	-25.94%	12.7%	322.31%	12815.58	-4.62%	10.51%	44.77%	19.89%	-22.35%	1.99%	191.7%	Basic Materials	402488.44	12.05%	12.22%	40.21	359044
Divis Laboratories Ltd	₹6,884.00	Large Cap	HOLD	6345.86	44.54%	50.46%	88.47%	213.15%	83.12	55.73	6.75	0.76	0.87%	662 Cr	12.39%	-12.28%	-19.37%	2585	11.47%	1%	12.56%	20.4%	0.83%	-13.15%	-28.37%	Basic Materials	182098.17	12.04%	16.27%	60.38	134693
Cipla Ltd	₹1,503.60	Large Cap	BUY	1653.25	-4.91%	0.93%	60.92%	134.44%	22.94	55.73	3.63	0.74	1.11%	1225.02 Cr	-22.65%	27.33%	106.72%	6597.72	-5.23%	6.88%	26.58%	19.21%	-18.38%	19.13%	63.32%	Basic Materials	120962.32	17.17%	21.4%	65.52	152360
Torrent Pharmaceuticals Ltd	₹3,295.50	Large Cap	BUY	3599.04	13.28%	18.04%	130.66%	179.68%	59.31	55.73	12.89	0.65	1.08%	498 Cr	-0.99%	33.02%	32.31%	2909	5.32%	11.51%	34.02%	15.44%	-6%	19.28%	-1.28%	Basic Materials	113353.82	20.43%	20.4%	48.94	213756
Dr Reddys Laboratories Ltd	₹1,281.20	Large Cap	HOLD	1268.74	-5.77%	-1.12%	45.92%	62.03%	18.72	55.73	4.22	0.62	0.65%	1586.7 Cr	13%	2.64%	162.32%	8506	1.76%	16.54%	51.51%	17.54%	11.04%	-11.93%	73.14%	Basic Materials	106058.65	20.15%	25.47%	68.65	808843
Zydus Lifesciences Ltd	₹994.05	Mid Cap	HOLD	983.55	-12.88%	-9.12%	175.93%	171.71%	22.13	55.73	6.43	0.79	0.3%	1248.8 Cr	24.35%	92.98%	80.31%	6290.2	22.77%	13.4%	35.71%	19.72%	1.28%	70.18%	32.86%	Basic Materials	100160.53	23.45%	22.73%	38.31	223954
Mankind Pharma Ltd	₹2,358.20	Mid Cap	BUY	2712.47	6.49%	11.46%	67.67%	67.67%	48.32	55.73	9.56	0.63	NA	424.65 Cr	10.44%	48.26%	50.17%	3079.37	-3.73%	18.12%	66.3%	18.79%	14.72%	25.52%	-9.7%	Pharmaceuticals	98423.43	20.95%	25.77%	48.47	100910
Lupin Ltd	₹1,943.50	Mid Cap	BUY	2259.97	15.04%	20.72%	213.29%	118.7%	27.35	55.73	3.58	0.8	0.49%	782.38 Cr	-8.9%	332.35%	57.63%	5562.2	-1%	20.25%	31.97%	9.67%	-7.98%	259.55%	19.44%	Basic Materials	89900	11.92%	13.96%	42.47	245210
Abbott India Ltd	₹35,485.00	Mid Cap	BUY	33417.5	22.9%	28.49%	87.17%	126.47%	0	55.73	15.48	0.49	NA	367.04 Cr	1.74%	16.35%	0%	1604.59	-0.6%	14.52%	0%	14.18%	2.35%	1.6%	0%	Basic Materials	75352.5	34.88%	44.71%	35.67	5489
Aurobindo Pharma Ltd	₹1,146.70	Mid Cap	BUY	1393.23	-10.05%	-6.52%	118.8%	48.87%	19.36	55.73	3.24	0.86	0.41%	902.83 Cr	6.77%	64.4%	-40.59%	8381.12	6.18%	16.68%	17.06%	10.93%	0.56%	40.89%	-49.25%	Basic Materials	67851.69	10.35%	11.74%	54.09	578850
Alkem Laboratories Ltd	₹4,833.10	Mid Cap	HOLD	5187.81	-6.43%	-1.93%	60.33%	107.37%	26.92	55.73	5.6	0.6	0.81%	323.01 Cr	-49.59%	79.92%	11.97%	3143.75	-6.83%	9.21%	42.89%	14.3%	-45.9%	64.75%	-21.64%	Basic Materials	58285.55	17.56%	17.28%	151.52	90631
Glaxosmithkline Pharmaceuticals Ltd	₹3,343.80	Mid Cap	BUY	3072	20.27%	26.5%	115.04%	124.66%	60.41	55.73	25.01	0.68	1.88%	262.87 Cr	14.35%	57.23%	-45.27%	974.37	2.63%	8.56%	14.37%	24.74%	11.42%	44.84%	-52.15%	Basic Materials	55798.96	49.23%	58.72%	54.76	28933

Why to invest in Pharma Stocks

Research and Development Focus: Pharma stocks are driven by a strong emphasis on research and development for the creation of innovative drugs.
Global Health Impact: Investing in pharma stocks aligns with contributing to global health and addressing medical challenges.
Stable Revenue Streams: These stocks often provide stable revenues due to consistent demand for medications and healthcare solutions.
Regulatory Resilience: Pharma stocks showcase resilience to regulatory changes, contributing to a stable investment environment.
Defensive Characteristics: Considered defensive, pharma stocks can offer stability during economic downturns.

Advantages of investing in Pharma Stocks

Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.

Points to consider before investing in Pharma Stocks

Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.

Check More Stocks

Name	Price	Analyst Rating	M Cap	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Adani Power Ltd	₹590.65	BUY	LARGE CAP	633.67	-22.29%	-17.32%	125.98%	1547.35%	18.36	30.34	4.74	1.18	2599.23 Cr	-11.59%	-38.79%	159.58%	14237.4	4.14%	11.62%	102.82%	22.68%	-15.11%	-45.16%	27.99%	Utilities	228099.37	26.75%	21.83%	33.06	1737464
Tata Motors Ltd	₹694.65	HOLD	LARGE CAP	770.21	-35.34%	-29.43%	68.58%	565.59%	11.04	37.55	7.42	1.27	8556 Cr	55.99%	-11.5%	-350.55%	118927	6.28%	1.31%	57.91%	6.4%	46.77%	-12.64%	-258.67%	Consumer Cyclical	253487.09	17.15%	18.21%	76.49	4536278
AWL Agri Business Ltd	₹258.15	BUY	SMALL CAP	322.67	-28.83%	-23.3%	-55.66%	-4.03%	27.3	58.4	3.57	0.81	176.52 Cr	-55.1%	581.65%	50.22%	18229.59	8.26%	24.3%	17.57%	1.83%	-58.53%	448.39%	27.77%	FMCG	33460.23	13.78%	20.03%	8.98	296084
Infosys Ltd	₹1,625.30	BUY	LARGE CAP	1650.51	-6.16%	-1.04%	8.23%	111.16%	24.97	33.35	7.47	1.08	7038 Cr	3.17%	1.91%	20.79%	40925	-2.01%	6.06%	33.99%	16.41%	5.28%	-3.91%	-9.85%	Technology	669045.61	30.35%	39.64%	64.52	1526750
Tata Steel Ltd	₹166.38	BUY	LARGE CAP	162.6	-10.47%	-5.95%	94.1%	402.82%	60.54	23.94	1.21	1.36	1200.88 Cr	306.4%	-164.64%	-92.4%	55706.99	4.65%	-4.64%	-10.42%	1.45%	288.34%	-167.79%	-91.51%	Industrials	207076.75	9%	10.52%	2.54	23933887
Yes Bank Ltd	₹20.22	SELL	MID CAP	16.64	-20.48%	-15.25%	60.32%	-22.45%	25.67	15.62	1.62	0.97	744.53 Cr	20.21%	74.66%	-136.84%	9437.85	0.23%	23.98%	42.4%	3.9%	19.93%	40.88%	-125.87%	Financial Services	63609.48	2.45%	NA	0.45	20820620
Eternal Ltd	₹261.30	BUY	LARGE CAP	274.3	18.72%	24.62%	378.36%	106.15%	432.92		6.95	1.24	39 Cr	-33.9%	-136.15%	-142.99%	5833	7.92%	71.13%	507.58%	2.9%	-38.75%	-121.12%	-107.08%	Technology	250667.86	5.15%	5.18%	0.4	7432343
ITC Ltd	₹413.20	BUY	LARGE CAP	500.26	-2.92%	-3.58%	41.47%	98.96%	15.06	16.31	7.41	0.65	19807.88 Cr	295.12%	68.92%	126.1%	18565.05	-0.08%	10.88%	24.16%	46.54%	295.44%	52.34%	82.11%	Consumer Defensive	516770.58	49.46%	36.71%	28.01	3238886
Wipro Ltd	₹270.00	HOLD	LARGE CAP	249.49	-6.29%	-0.93%	27.05%	137.54%	21.25	33.35	4.36	1.16	3588.1 Cr	6.58%	18.95%	7.96%	22504.2	0.83%	-0.75%	12.33%	14.84%	5.7%	19.85%	-3.89%	Technology	279877.89	17.89%	21.54%	12.62	3581346
HDFC Bank Ltd	₹2,006.60	BUY	LARGE CAP	2184.46	9.25%	12.29%	46.5%	84.92%	21.4	15.62	2.5	0.88	18834.88 Cr	6.67%	39.27%	101.24%	120268.76	7.2%	99.35%	161.73%	15.7%	-0.49%	-30.13%	-23.11%	Financial Services	1522847.65	16.88%	NA	86.15	2355699

Frequently Asked Questions

What are pharma stocks?

Pharma stocks represent publicly traded companies involved in researching, developing, manufacturing, and marketing pharmaceutical drugs and treatments. These companies play a vital role in advancing healthcare and stand to benefit from successful product launches and growing healthcare needs.

What are the risks of pharma stocks?

High R&D Costs: Developing new drugs is expensive and time-consuming, with a high risk of failure during clinical trials, potentially impacting stock prices.
Regulatory Hurdles: Strict government regulations can delay drug approvals, hindering a company's ability to bring products to market.
Patent Expiry: Once a drug's patent expires, generic competition can significantly reduce profitability.
Economic Downturns: Healthcare spending can be impacted by economic downturns, potentially affecting pharma companies' revenues

How to identify promising pharma stocks?

Strong R&D Pipeline: Look for companies with a robust pipeline of drugs in various stages of development.
Focus on Innovation: Companies prioritising innovative therapies or addressing unmet medical needs can be attractive.
Financials: Evaluate a company's financial health, considering factors like profitability, debt levels, and cash flow.
Regulatory Environment: Understanding the regulatory landscape in the company's target markets is crucial.

Is diversification important when investing in Pharmaceuticals Sector Stocks?

Diversification is crucial when investing in pharmaceutical sector stocks. While the industry presents significant growth opportunities, it also entails considerable risks and uncertainties, including patent expirations, regulatory hurdles, and potential clinical trial failures, among others.

By spreading investments across multiple pharmaceutical companies, investors can mitigate risk and lessen the potential negative impact on overall returns. This approach allows for a balance between potential gains and losses, ultimately improving the performance and stability of returns.

How do changes in government policies and regulations affect pharmaceutical sector stocks?

Government policy changes can have a significant impact on pharmaceutical sector stocks. In particular, government decisions related to reimbursement rates, intellectual property rights, and drug pricing can greatly influence the market potential and profitability of pharmaceutical companies.

Explore Stocks Category:

INDmoney is 100% Safe and Secure!

Your security and privacy are our top priority!

27001:2022
ISO Certified
Audited by
cert-in empanelled auditors
AES 256-BIT
SSL Secured